Movement Alert｜Eli Lilly Rises 3.36% in Regular Trading, Multiple Banks Raise Target Prices as Mounjaro Wins Pediatric Approval in Canada

Market Focus

Jul 07

On July 7, Eli Lilly rose 3.36% in regular trading, reaching $1,235.14/share and hitting a fresh all-time high, with total market capitalization surpassing $1.18 trillion. The rally was driven by multiple investment bank upgrades and a key regulatory approval for its blockbuster diabetes drug.

JPMorgan raised its price target on Eli Lilly from $1,300 to $1,400, implying approximately 17% upside from current levels. Analyst Chris Schott projected quarterly revenue of $20.7 billion and EPS of $8.85, both above consensus, citing continued international expansion of Mounjaro and robust U.S. obesity market growth. Cantor Fitzgerald also lifted its target from $1,230 to $1,350.

Separately, Health Canada officially approved Mounjaro (tirzepatide) for treatment of type 2 diabetes in patients aged 10 and older, further broadening the drug's addressable patient population. The broader pharmaceutical sector traded higher, with Johnson & Johnson up 3.2%, Pfizer up 1.54%, and Novo Nordisk up 1.42%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1110884122"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1110884122\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1110884122?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-07 22:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110884122","market":"us","top_or_hot":-1,"title":"Movement Alert｜Eli Lilly Rises 3.36% in Regular Trading, Multiple Banks Raise Target Prices as Mounjaro Wins Pediatric Approval in Canada","media":"Market Focus","content":"<p><p>On July 7, Eli Lilly rose 3.36% in regular trading, reaching $1,235.14/share and hitting a fresh all-time high, with total market capitalization surpassing $1.18 trillion. The rally was driven by multiple investment bank upgrades and a key regulatory approval for its blockbuster diabetes drug.</p><p>JPMorgan raised its price target on Eli Lilly from $1,300 to $1,400, implying approximately 17% upside from current levels. Analyst Chris Schott projected quarterly revenue of $20.7 billion and EPS of $8.85, both above consensus, citing continued international expansion of Mounjaro and robust U.S. obesity market growth. Cantor Fitzgerald also lifted its target from $1,230 to $1,350.</p><p>Separately, Health Canada officially approved Mounjaro (tirzepatide) for treatment of type 2 diabetes in patients aged 10 and older, further broadening the drug's addressable patient population. The broader pharmaceutical sector traded higher, with Johnson & Johnson up 3.2%, Pfizer up 1.54%, and Novo Nordisk up 1.42%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Eli Lilly Rises 3.36% in Regular Trading, Multiple Banks Raise Target Prices as Mounjaro Wins Pediatric Approval in Canada</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Eli Lilly Rises 3.36% in Regular Trading, Multiple Banks Raise Target Prices as Mounjaro Wins Pediatric Approval in Canada\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-07 22:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 7, Eli Lilly rose 3.36% in regular trading, reaching $1,235.14/share and hitting a fresh all-time high, with total market capitalization surpassing $1.18 trillion. The rally was driven by multiple investment bank upgrades and a key regulatory approval for its blockbuster diabetes drug.</p><p>JPMorgan raised its price target on Eli Lilly from $1,300 to $1,400, implying approximately 17% upside from current levels. Analyst Chris Schott projected quarterly revenue of $20.7 billion and EPS of $8.85, both above consensus, citing continued international expansion of Mounjaro and robust U.S. obesity market growth. Cantor Fitzgerald also lifted its target from $1,230 to $1,350.</p><p>Separately, Health Canada officially approved Mounjaro (tirzepatide) for treatment of type 2 diabetes in patients aged 10 and older, further broadening the drug's addressable patient population. The broader pharmaceutical sector traded higher, with Johnson & Johnson up 3.2%, Pfizer up 1.54%, and Novo Nordisk up 1.42%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LLY","symbol_name":"礼来","start_time":0,"source_url":"","article_id":"1110884122","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110884122","pubTimestamp":1783434158,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 7, Eli Lilly rose 3.36% in regular trading, reaching $1,235.14/share and hitting a fresh all-time high, with total market capitalization surpassing $1.18 trillion. The rally was driven by...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LLY":"礼来"},"translate_title":"动向提示|礼来常规交易涨3.36%Mounjaro获加拿大儿科批准多家银行上调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":1},"content_text":"On July 7, Eli Lilly rose 3.36% in regular trading, reaching $1,235.14/share and hitting a fresh all-time high, with total market capitalization surpassing $1.18 trillion. The rally was driven by multiple investment bank upgrades and a key regulatory approval for its blockbuster diabetes drug.JPMorgan raised its price target on Eli Lilly from $1,300 to $1,400, implying approximately 17% upside from current levels. Analyst Chris Schott projected quarterly revenue of $20.7 billion and EPS of $8.85, both above consensus, citing continued international expansion of Mounjaro and robust U.S. obesity market growth. Cantor Fitzgerald also lifted its target from $1,230 to $1,350.Separately, Health Canada officially approved Mounjaro (tirzepatide) for treatment of type 2 diabetes in patients aged 10 and older, further broadening the drug's addressable patient population. The broader pharmaceutical sector traded higher, with Johnson & Johnson up 3.2%, Pfizer up 1.54%, and Novo Nordisk up 1.42%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}